Eton Pharmaceuticals, Inc.
ETON
$16.90
-$2.24-11.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.12M | 25.38M | 17.42M | 14.94M | 20.26M |
| Total Receivables | 13.08M | 14.45M | 16.40M | 5.36M | 5.59M |
| Inventory | 16.86M | 23.79M | 13.62M | 15.23M | 1.94M |
| Prepaid Expenses | 4.94M | 4.82M | 2.52M | 5.49M | 1.96M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.00M | 68.44M | 49.96M | 41.02M | 29.75M |
|
|
|||||
| Total Current Assets | 72.00M | 68.44M | 49.96M | 41.02M | 29.75M |
| Net Property, Plant & Equipment | 613.00K | 342.00K | 180.00K | 209.00K | 226.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.88M | 32.88M | 33.88M | 34.88M | 5.85M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.00K | 12.00K | 12.00K | 12.00K | 12.00K |
| Total Assets | 104.51M | 101.68M | 84.03M | 76.12M | 35.84M |
|
|
|||||
| Total Accounts Payable | 14.26M | 12.14M | 4.87M | 4.17M | 2.68M |
| Total Accrued Expenses | 24.16M | 23.66M | 20.40M | 15.70M | 12.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.81M | 2.79M | 77.00K | 76.00K | 4.20M |
| Total Finance Division Other Current Liabilities | 2.96M | -- | -- | -- | -- |
| Total Other Current Liabilities | 2.96M | -- | -- | -- | -- |
| Total Current Liabilities | 44.18M | 38.60M | 25.35M | 19.95M | 19.73M |
|
|
|||||
| Total Current Liabilities | 44.18M | 38.60M | 25.35M | 19.95M | 19.73M |
| Long-Term Debt | 27.59M | 27.41M | 29.99M | 29.81M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 480.00K | 492.00K | 87.00K | 107.00K | 126.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.13M | 11.22M | 4.15M | 1.83M | -- |
| Total Liabilities | 81.38M | 77.72M | 59.58M | 51.70M | 19.86M |
|
|
|||||
| Common Stock & APIC | 137.10M | 136.01M | 133.92M | 132.32M | 123.28M |
| Retained Earnings | -113.98M | -112.05M | -109.47M | -107.89M | -107.30M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 23.13M | 23.96M | 24.45M | 24.43M | 15.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.13M | 23.96M | 24.45M | 24.43M | 15.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.13M | 23.96M | 24.45M | 24.43M | 15.98M |
|
|
|||||